173 related articles for article (PubMed ID: 19806025)
1. p53 negatively regulates expression of FoxM1.
Pandit B; Halasi M; Gartel AL
Cell Cycle; 2009 Oct; 8(20):3425-7. PubMed ID: 19806025
[TBL] [Abstract][Full Text] [Related]
2. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
[TBL] [Abstract][Full Text] [Related]
3. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.
Tan Y; Raychaudhuri P; Costa RH
Mol Cell Biol; 2007 Feb; 27(3):1007-16. PubMed ID: 17101782
[TBL] [Abstract][Full Text] [Related]
4. Pro-proliferative FoxM1 is a target of p53-mediated repression.
Barsotti AM; Prives C
Oncogene; 2009 Dec; 28(48):4295-305. PubMed ID: 19749794
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 and polo-like kinase 1 are co-ordinately overexpressed in patients with gastric adenocarcinomas.
Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Sharrocks AD; Ang YS
BMC Res Notes; 2015 Nov; 8():676. PubMed ID: 26576650
[TBL] [Abstract][Full Text] [Related]
7. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.
Zhang X; Cheng L; Minn K; Madan R; Godwin AK; Shridhar V; Chien J
Oncotarget; 2014 Nov; 5(22):11365-80. PubMed ID: 25426548
[TBL] [Abstract][Full Text] [Related]
8. Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription.
Tan Y; Chen Y; Yu L; Zhu H; Meng X; Huang X; Meng L; Ding M; Wang Z; Shan L
Cell Prolif; 2010 Oct; 43(5):494-504. PubMed ID: 20887555
[TBL] [Abstract][Full Text] [Related]
9. [Effects and molecular mechanisms of inhibiting FOXM1 expression on ovarian cancer cell line SKOV3 by Lentiviral vector].
Chen GQ; Yao ZW; Qi HB; Zhang H; Luo Y; Qin XF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):29-32. PubMed ID: 22230500
[TBL] [Abstract][Full Text] [Related]
10. FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression.
Li SK; Smith DK; Leung WY; Cheung AM; Lam EW; Dimri GP; Yao KM
J Biol Chem; 2008 Jun; 283(24):16545-53. PubMed ID: 18408007
[TBL] [Abstract][Full Text] [Related]
11. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of polo-like kinase 1 in human cancers.
Weng Ng WT; Shin JS; Roberts TL; Wang B; Lee CS
J Clin Pathol; 2016 Jul; 69(7):557-62. PubMed ID: 26941182
[TBL] [Abstract][Full Text] [Related]
15. Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension.
Wilson JL; Wang L; Zhang Z; Hill NS; Polgar P
PLoS One; 2019; 14(8):e0221728. PubMed ID: 31437238
[TBL] [Abstract][Full Text] [Related]
16. The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma.
Dibb M; Han N; Choudhury J; Hayes S; Valentine H; West C; Ang YS; Sharrocks AD
Br J Cancer; 2012 Nov; 107(10):1766-75. PubMed ID: 23037713
[TBL] [Abstract][Full Text] [Related]
17. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma.
Wang Z; Zheng Y; Park HJ; Li J; Carr JR; Chen YJ; Kiefer MM; Kopanja D; Bagchi S; Tyner AL; Raychaudhuri P
Mol Cancer Ther; 2013 May; 12(5):759-67. PubMed ID: 23427295
[TBL] [Abstract][Full Text] [Related]
18. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M
Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
